Evox Therapeutics
PrivateLast Round
Series C
Feb 18, 2021
Total Funding Raised
$158.25M
Company Overview
Evox Therapeutics is a biotechnology company that develops exosome-based therapeutics for the treatment of severe rare, neurological, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evox Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Evox Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 18, 2021 | ||||
| Grant | Mar 22, 2019 | ||||
| Grant | Nov 13, 2018 | ||||
| Grant | Oct 1, 2018 | ||||
| Series B | Sep 3, 2018 | ||||
Series A | May 11, 2016 |
Evox Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B, Series C |
| Innovate UK | Grant |
| UK government | Grant |
| GV | Series B, Series C |
| Duchenne UK | Grant |
| Oxford Science Enterprises | Series B, Series C, Series A |
| TD Securities | Series B, Series C |
Evox Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evox Therapeutics's valuation, stock price, and market status.
